Focus on Innovative Financing for Health. The Global Fund. (2016)


Smart, effective health investments through the Global Fund have saved 17 million lives, expanding opportunities and achieving greater social justice for families and communities worldwide. Scientific advances, innovative ideas and private sector expertise are unlocking improvements in disease prevention, treatment and care.


Keywords: HIV, TB, funding, governments, domestic financing



Download Publication

UNAIDS and the Global Fund. UNAIDS. (2016)


Over the past three decades, historic progress has transformed HIV from a deadly disease to a chronic condition. Critical milestones have been reached towards universal access: more than 17 million people globally are receiving HIV treatment, and the world is on track to eliminate mother to child transmission of HIV.

Still, more than 2 million people are newly infected with HIV annually. Last year alone 1.1 million people needlessly lost their lives and HIV remains one of the leading causes of death among children under five years old, adolescents and women of reproductive age. Since the beginning of the epidemic, more than 70 million people have died due to AIDS. Despite the extraordinary progress, HIV remains a serious challenge for global health and development goals.

Keywords: HIV,investment, resources, support

Download Publication

Financing the Response to HIV in Low- and Middle-Income Countries. Kates J, Wexler A and Lief E. (2015)


As world leaders meet to discuss the future of financing for development and to endorse new Sustainable Development Goals (SDGs) in the post-MDG era, the global community is taking stock of the progress made as well as the work that remains to be done, including in addressing the HIV epidemic. Since the establishment of the MDGs in 2000, through 2013 new HIV infections have decreased by almost 40% and the number of AIDSrelated deaths has decreased by 35% since 2005. Still, in 2013, more than million people were newly infected with HIV and 1.5 million died. In addition, new infections are rising in some parts of the world and some groups continue to be at disproportionately high risk for HIV and lack access to needed treatment and other interventions. As a result, a new UNAIDS Lancet Commission Report on Defeating AIDS calls for a significant ramping up of funding for AIDS efforts now, stating that “the next 5 years present a window of opportunity to scale up the AIDS response to end AIDS as a public health problem by 2030”. While the Commission notes that affected countries with financial capacity should fund more of their AIDS response, the need for international funding, particularly from donor governments, remains high. UNAIDS and the Kaiser Family Foundation have been tracking donor government assistance provided to address HIV in low- and middle-income countries since 2002. This report provides data from 2014, the latest available on their funding.

Keywords: HIV, donors, governments, funding, data, Kaiser Family Foundation

Download Publication

HIV Prevention Research and Development Funding Trends, 2000–2014. AVAC, International AIDS Vaccine Initiative and UNAIDS. (2015)


In its eleventh annual report, the HIV Vaccines & Microbicides Resource Tracking Working Group (the “Working Group”) documents biomedical HIV prevention research and development (R&D1) spending for the calendar year 2014, as well as reports on an analysis of investment trends spanning fourteen years. The Working Group generates estimates of R&D investment that can be compared year to year across options and strategies and funding sources, helping assess the impact of public policies aimed at accelerating scientific progress and to provide facts for advocacy. This effort provides transparency for funders, policy makers and HIV/AIDS advocates so they can better understand and track investment flows.


Keywords: HIV, prevention funding, investments, AIDS vaccines, PrEP

Download Publication

Unfinished Business: Tracking Global Commitments on AIDS, Volume 4. Hohlfelder E and Lluberes C. (2015)


We have made incredible progress in the global fight against HIV/AIDS. But we are starting to see a dangerous level of complacency which threatens to reverse the real achievements made so far.

The world stands at a critical juncture: if we act with urgency in the next five years, we could end AIDS as an epidemic by 2030. But achieving this goal will require $12 billion annually more by 2020, targeted more effectively to reach the most vulnerable. Our new report calls on governments to prioritize support for the Global Fund; leaders in sub-Saharan Africa to invest more domestic resources in health; and the private sector to play a greater role.


Keywords: HIV, AIDS, ARV, treatment, spending, funding, donors 


Download publication


Download methodology

Scaling up HIV Treatment for MSM in Bangkok: What Does It Take? — A Modelling and Costing Study. Zhang L, Phanuphak N, Henderson K, et al. (2015)


The HIV epidemic amongst men who have sex with men (MSM) in Bangkok is substantial. The population size of MSM in Bangkok is 120,000-250,000, with approximately one-third (33.5 percent) considered high-risk, characterized by their young age, multiple partnerships, frequent unprotected anal intercourse, and sexual activities around MSM hotspots. In metropolitan Bangkok, HIV prevalence among MSM reportedly increased from 21 percent to 28 percent between 2000 and 2012. The Thai Working Group of Estimation and Projection (2013) projected an estimate of 39,000 new HIV infections would occur in Thailand during 2012-2016, based on the AIDS Epidemic Model (AEM). 

Keywords: HIV, transmission, heterosexual, epidemic, infections, cost-effectiveness

Download Publication

Investing for Results: How Asia Pacific Countries Can Invest for Ending AIDS. Rao JVRP, Chan R, Gilling J, Kunii O, et al. (2015)


This report examines the resource challenges that confront the AIDS response in Asia and the Pacific. It proposes a set of interventions that will help overcome them and steer the region towards ending its AIDS epidemic.

The report summarizes the analysis done by an independent, expert advisory panel on AIDS funding in Asia and the Pacific, convened jointly by UNAIDS and the World Bank in August 2013. The Expert Panel was tasked with reviewing the prospects for ending the region’s AIDS epidemic in the context of changing global economy and external funding environment.


Keywords: HIV, AIDS, prevention, testing, treatment, funding, global fund

Download Publication

Game Changers, Success Stories, Lessons Learned: The ADB Cooperation Fund for Fighting HIV/AIDS in Asia and the Pacific. ADB. (2015)


While the response to the region’s HIV epidemic has chalked up impressive gains in HIV prevention and treatment, too many people continue to fall through the gaps in existing services.

The ADB Cooperation Fund for Fighting HIV/AIDS in Asia and the Pacific benefitted from a $19.2 million grant from the Government of Sweden with the goal of assisting ADB’s developing member countries meet their commitment to Millennium Development Goal 6, target 6A: to have halted by 2015 and begun to reverse the spread of HIV. The objective of the fund was to support these countries to develop a comprehensive AIDS response; enable them to partner with ADB in areas that play to the bank’s strategic value and advantages; and particularly to benefit subregions, countries and communities that are most vulnerable to HIV. 

This report summarizes the experiences and lessons learned of the Cooperation Fund.

Keywords: data, new infections, treatments, sex work, PLHIV, MDG

Download main report


Download summary sheets

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Fiji. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

The Trans-Pacific Partnership Agreement: Implications for Access to Medicines and Public Health. Bhardwaj K and Oh C. (2014)


The objective of this report is to provide an analysis of the provisions in the proposed TPPA in order to obtain a clearer understanding of their implications. It is hoped that the report will also be a useful resource for other stakeholders in the public health field.


The report analyses the key negotiating issues in the USA’s proposals (widely considered to be the basic negotiation text for the TPPA) which are likely to have an impact on access to medicines and public health.


Analysis in this report is based on negotiation texts that were leaked and made available in the public domain in 2011 and 2012. The main texts include the USA’s proposals for chapters on intellectual property, on the regulation of pharmaceutical reimbursement programmes and on investment. It should be borne in mind that it may not be possible to provide a comprehensive examination of all relevant provisions or to assess fully how these provisions will impact and interact with other parts of the TPPA (which are not currently in the public domain). Moreover, as long as the negotiations are ongoing, the text may evolve and change.

Download Publication


Highlighted publications
Calendar of events
(17 May - 17 May)
(28 Jul - 28 Jul)